^○Jorge Illarramendi¹, Natalia Larrea², Esteban Salgado³, Susana De La Cruz³, Jose Juan Illarramendi³ (1.Service of Hematology, University Hospital of Navarre, 2.Service of Hospital Pharmacy, University Hospital of Navarre, 3.Service of Medical Oncology, University Hospital of Navarre)

^○Tianyu Zeng, Wei Li, Chunxiao Sun, Xueqi Yan, Fan Yang, Yan Liang, Ziyi Fu, Yongmei Yin (Department of Oncology, the First Affiliated Hospital of Nanjing Medical University)

^○Vaibhav Choudhary¹, Satheesh C T², Chinmoy K Bose³, Shiv Rajan⁴, Prakash Ss⁵, Chirag Desai⁶, Xiao Lin⁷, Balaji Patil⁸, Sameer Chaudhari⁸, Sudeep Gupta⁹ (1.HCG NCHRI Cancer Centre, Nagpur, India, 2.Global HealthCare Enterprises Ltd, Bangalore, 3.Netaji Subhash Chandra Bose Cancer Institute, Kolkata, 4.King George's Medical University, Lucknow, 5.KR Hospital Mysore Medical College& Research Institute, Mysore, 6.Hemato-Oncology Clinic, Vedanta Institute of Medical Sciences, Ahmedabad, 7.Eisai Co. Ltd, Japan, 8.Eisai Pharmaceuticals India Pvt. Ltd, India, 9.Tata Memorial Hospital, Mumbai)

^○Billie E. Herijanto¹, Jeremy O. Sugianto¹, Marchella Tjandra¹, Velin Jonathan¹, William S. Atmaja¹, Natasha K. Law¹, Andree Kurniawan² (1.Faculty of Medicine, Pelita Harapan University, 2.Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University)

^○Tsutomu Iwasa¹, Kazuhiko Nakagawa¹, Shiho Takehisa², Kimiko Fujiwara³, Yoshifumi Komoike⁴, Esuther Hirokawa¹, Satomi Watanabe⁵ (1.Department of Medical Oncology, Faculty of Medicine, Kindai University, 2.Department of Nursing, Kindai University, 3.Department of Pharmacy, Kindai University, 4.Department of Endocrine Breast Surgery, Kindai University, 5.Department of Medical Oncology, Kishiwada City Hospital)

^○Kenichi Watanabe, Sayuri Kuwahara, Hanae Tachikawa, Hideki Maeda, Mitsugu Yamamoto, Nobumoto Tomioka, Masato Takahashi (Department of Breast Surgery, Hokkaido Cancer Center)

^○Ayumi Saito, Tatsunori Shimoi, Shu Yazaki, Shousuke Kita, Momoko Tokura, Chiharu Mizoguchi, Yamamoto Kasumi, Yuki Kojima, Hitomi Okuma, Tadaaki Nishikawa, Nogushi Emi, Kazuki Sudo, Kan Yonemori (Department of Medical Oncology, National Cancer Center Hospital)

^○Hiroji Iwata¹, Andre Fabrice², Im Seock-Ah³, Neven Patrick⁴, D Baird Richard⁵, Ettl Johannes⁶, P Goetz Matthew⁷, Hamilton Erika⁸, Jiang Zefei⁹, Abraham Joy Anil¹⁰, Haddad Vincent¹¹, Walding Andrew¹², Selvi Miralles Manuel¹², Huang-Bartlett Cynthia¹², Llombart-Cussac Antonio¹³ (1.Aichi Cancer Center Hospital, 2.Institut Gustave Roussy, 3.Seoul National University Hospital, 4.Universitair Ziekenhuis, 5.Cancer Research UK Cambridge Centre, 6.Technical University of Munich, 7.Mayo Clinic, 8.Sarah Cannon Research Institute and Tennessee Oncology, 9.The Fifth Medical Centre of Chinese PLA General Hospital, 10.Department of Oncology, University of Alberta, Cross Cancer Institute, 11.Oncology Biometrics, AstraZeneca, 12.Late Development, Oncology R&D, AstraZeneca, 13.Hospital Arnau de Vilanova)

^○Mariko Sato¹, Sugiyama Keiji¹, Shiraishi Kazuhiro¹, Nishibori Riko¹, Kato Kyoko¹, Funahashi Yoriko¹, Kato Aya², Hayashi Takako², Morita Takako², Kitagawa Chiyoe¹ (1.Department of Medical Oncology, NHO Nagoya Medical Center, 2.Department of Breast Surgery, NHO Nagoya Medical Center)

^○Tomomi Fujisawa (Department of Breast Oncology, Gunma Prefectural Cancer Center)

^○Mio Adachi, Yuichi Kumaki, Chiaki Saita, Naoko Iwamoto, Rika Yonekura, Toshiyuki Ishiba, Noriko Nakatsugawa, Yayoi Honda, Tomoyuki Aruga (Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital)

^○Jean A. Liem¹, Andree Kurniawan², Joysya Christiano¹, Teresa M. Argo¹, Natasha K. Law¹, Darlene Asafia¹ (1.Faculty of Medicine, Pelita Harapan University, 2.Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University)